Trial Profile
Evaluation of the effect of FYX-051 on cardiac repolarization : a thorough QT/QTc study
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 May 2016
Price :
$35
*
At a glance
- Drugs Topiroxostat (Primary)
- Indications Gout; Hyperuricaemia
- Focus Adverse reactions
- Sponsors Fuji Yakuhin; Sanwa Kagaku Kenkyusho
- 29 Mar 2014 Title not official title and phase assumed.
- 29 Mar 2014 New trial record